Despite geopolitical uncertainty, the biopharma sector shows strong momentum in 2026 with robust M&A activity, improving investor sentiment, and continued scientific innovation, supported in part by data tracked by DealForma. Read it here
Despite geopolitical uncertainty, the biopharma sector shows strong momentum in 2026 with robust M&A activity, improving investor sentiment, and continued scientific innovation, supported in part by data tracked by DealForma. Read it here
DealForma is the biopharma deal database providing you comprehensive information and dedicated analyst support to help you be more confident using quality data in your business development research.
Database
Company
Comparisons
Website Design by Once Interactive
